Dermatology News and Research

Latest Dermatology News and Research

Combining nanomedicine with two anticancer treatments could improve outcomes for pancreatic cancer patients

A nanoparticle drug-delivery system that combines two complementary types of anticancer treatment could improve outcomes for patients with pancreatic cancer and other highly treatment-resistant tumors while decreasing toxicity.

20 Jan 2016

Arrhythmias worth treating in PAH patients

Supraventricular arrhythmias are common in patients with pulmonary arterial hypertension but can be successfully managed with standard treatments, a study shows.

19 Jan 2016

Salvat, Lee's Pharmaceutical partner to market Duoxal ear drops in Greater China

Laboratorios SALVAT, S.A. and Lee's Pharmaceutical (HK) Limited, a wholly-owned subsidiary of Lee's Pharmaceutical Holdings Limited, jointly announced today the signing of an exclusive License and Supply Agreement for the marketing and distribution of Duoxal ear drops (patented combination solution of Ciprofloxacin and Fluocinolone Acetonide) in the People's Republic of China, Hong Kong S.A.R., Macau S.A.R., and Taiwan and an option to add Thailand to the contractual territory.

12 Jan 2016

Physicians may soon have new tool to closely track severity, potential spread of metastatic melanoma

Physicians treating patients with metastatic melanoma — one of the most aggressive forms of skin cancer — may soon have a superior tool in their efforts to closely track the disease.

12 Jan 2016

Strathspey Crown Holdings announces acquisition of Novus Via assets

Strathspey Crown Holdings LLC announced today the acquisition of the portfolio companies of Novus Via LP, a Nevada-based venture capital investment firm focused on end-stage development and commercialization of advanced electromagnetic and electrochemical technologies spanning healthcare, clean energy and coherent acoustics. The terms of the transaction were not disclosed.

11 Jan 2016

SillaJen reports initiation of multinational randomized Phase 3 study of Pexa-Vec in HCC patients

SillaJen, Inc., a private, clinical-stage, biotherapeutics company focused on the development of oncolytic immunotherapy products for cancer, has announced the initiation of a multinational randomized Phase 3 open-label study of its lead product candidate, Pexa-Vec (formerly JX-594), in patients with advanced liver cancer, also known as hepatocellular carcinoma (HCC).

5 Jan 2016

Immune enters into exclusive license with Atlante Biotech for new format of bispecific antibodies

Immune Pharmaceuticals Inc. a clinical-stage company developing novel therapies for the treatment of immuno-inflammatory diseases and cancer, today announced it has entered into an exclusive license with Atlante Biotech SAS, to the patents and know-how for a new format of bispecific antibodies.

29 Dec 2015

Benjamin Wolozin receives $500,000 award in Alzheimer's Disease Drug Discovery Research

Research that leads to improved therapies for Alzheimer's disease (AD) patients is one goal of Boston University School of Medicine professor of pharmacology and neurology Benjamin Wolozin, MD, PhD. He was one of six researchers awarded a two-year, $500,000 award in Alzheimer's Disease Drug Discovery Research by the Edward N. & Della L. Thome Memorial Foundation.

22 Dec 2015

Nuvo Research announces topline results from WF10 Phase 2 trial for treatment of allergic rhinitis

Nuvo Research Inc., a life sciences company with growing revenues and a diverse portfolio of topical products, today announced the results of its investigational Phase 2 clinical trial of WF10 (Trial) for the treatment of allergic rhinitis.

21 Dec 2015

ALPHAEON announces acquisition of Rocol SA

ALPHAEON Corporation, a social commerce company and subsidiary to Strathspey Crown Holdings LLC, today announced its acquisition of Rocol SA, a leader in the commercialization of medical equipment across Latin America. Terms of the acquisition were not disclosed.

18 Dec 2015

ALPHAEON agrees to bring Zelegent's office-based Elevoplasty technology to sleep specialists

ALPHAEON Corporation, a subsidiary of Strathspey Crown Holdings LLC, and Zelegent, Inc. jointly announced today that the two companies have entered into an exclusive worldwide agreement to bring Zelegent's office-based Elevoplasty technology to board certified sleep specialists.

15 Dec 2015

New home in medical applications for Morgan Advanced Materials D36 ceramics

Morgan Advanced Materials, a global leader in Radio Frequency (RF) and microwave ceramic materials, has established a major application for its proven D36 microwave ceramic.

14 Dec 2015

Irradiated white blood cells release substances that have positive effect upon tissue repair

Hendrik Jan Ankersmit's research group at the Clinical Department of Thoracic Surgery of MedUni Vienna has successfully shown that irradiated white blood cells release substances that reduce the severity of the damage caused by a heart attack or stroke and in spinal injuries and have a positive effect upon tissue repair. However, up until now it wasn't known exactly which particular substances were responsible for these beneficial effects. This has now been discovered.

14 Dec 2015

RV glucose metabolism changes associated with RV function

The rate of myocardium glucose utilisation in the right ventricle correlates with its function and could be used to monitor treatment effects in patients with pulmonary arterial hypertension, findings indicate.

11 Dec 2015

Right atrial function could be prognostic in PAH

Right atrial function is impaired in patients with pulmonary arterial hypertension and may indicate right ventricular overload and failure, research suggests.

11 Dec 2015

Patients and providers satisfied with video-based health care, shows study

More than 50 million Americans live in rural areas, and many have limited access to health care. For someone living far from an urban area, local specialty care for complex health issues is difficult, if not impossible, to obtain. For years, telemedicine programs across the country have connected rural patients to specialists in urban settings. Now, a study by University of Missouri School of Medicine researchers shows that patients and providers alike are satisfied with video-based health care.

9 Dec 2015

Economic and racial barriers impact treatment of moderate to severe psoriasis

In the first known study to examine the prevalence and treatment of psoriasis in older Americans, experts from the Perelman School of Medicine at the University of Pennsylvania have found that black patients receiving Medicare are less likely to receive biologic therapies -medications derived from human or animal cells or tissues - for the treatment of moderate to severe psoriasis than white patients.

9 Dec 2015

Children with allergic disease have higher risk of heart disease

Children with allergic disease, particularly asthma and hay fever, have about twice the rate of high blood pressure and high cholesterol, setting them on a course for heart disease at a surprisingly early age, reports a new Northwestern Medicine study.

8 Dec 2015

One Medical Group raises $65 million in growth capital to support accelerated market expansion

One Medical Group, the national leader in technology-enabled primary care, today announced that it has raised $65 million of growth capital to support accelerated market expansion. The round was led by J.P. Morgan Asset Management on behalf of PEG Digital Growth Fund II L.P. and AARP Innovation Fund L.P. Current and new institutional and individual investors also participated.

8 Dec 2015

New Northwestern Medicine project aims to understand effects of asthma, eczema on children

A new Northwestern Medicine project, "Asthma and Atopic Dermatitis Validation of PROMIS Pediatric Instruments" (AAD-PEPR), will focus on two common childhood diseases that affect almost 25 percent of American children under age 18.

1 Dec 2015

Dermatology News and Research

Latest Dermatology News and Research

Combining nanomedicine with two anticancer treatments could improve outcomes for pancreatic cancer patients

Arrhythmias worth treating in PAH patients

Salvat, Lee's Pharmaceutical partner to market Duoxal ear drops in Greater China

Physicians may soon have new tool to closely track severity, potential spread of metastatic melanoma

Strathspey Crown Holdings announces acquisition of Novus Via assets

SillaJen reports initiation of multinational randomized Phase 3 study of Pexa-Vec in HCC patients

Immune enters into exclusive license with Atlante Biotech for new format of bispecific antibodies

Benjamin Wolozin receives $500,000 award in Alzheimer's Disease Drug Discovery Research

Nuvo Research announces topline results from WF10 Phase 2 trial for treatment of allergic rhinitis

ALPHAEON announces acquisition of Rocol SA

ALPHAEON agrees to bring Zelegent's office-based Elevoplasty technology to sleep specialists

New home in medical applications for Morgan Advanced Materials D36 ceramics

Irradiated white blood cells release substances that have positive effect upon tissue repair

RV glucose metabolism changes associated with RV function

Right atrial function could be prognostic in PAH

Patients and providers satisfied with video-based health care, shows study

Economic and racial barriers impact treatment of moderate to severe psoriasis

Children with allergic disease have higher risk of heart disease

One Medical Group raises $65 million in growth capital to support accelerated market expansion

New Northwestern Medicine project aims to understand effects of asthma, eczema on children

Industry Focus eBook - Cell & Gene Therapy (1st Edition) eBook

Real-time Raman monitoring for pharmaceutical hot melt extrusion

Synthetic Psychedelics: A Growing Public Health Concern

How the Vutara VXL simplifies single-molecule imaging

Dermatology News and Research

Latest Dermatology News and Research

Industry Focus eBook - Cell & Gene Therapy (1st Edition) eBook

Real-time Raman monitoring for pharmaceutical hot melt extrusion

Synthetic Psychedelics: A Growing Public Health Concern

How the Vutara VXL simplifies single-molecule imaging

Newsletters you may be interested in